Characterization of isolated amyloid myopathy.
Teerin LiewluckMargherita MilonePublished in: European journal of neurology (2017)
Isolated amyloid myopathy accounts for 27% of patients with amyloid myopathy, mostly due to anoctaminopathy-5. There are various clinical and laboratory parameters that can help to differentiate isolated amyloid myopathy from systemic amyloidosis.
Keyphrases